From: Fralick M, Colacci M, Schneeweiss S, et al. Effectiveness and safety of apixaban compared with rivaroxaban for patients with atrial fibrillation in routine practice. A cohort study. Ann Intern Med. 2020;172:463-73. doi:10.7326/M19-2522
Effectiveness and Safety of Apixaban Versus Rivaroxaban for Patients With Atrial Fibrillation. Ann Intern Med. 2020;172:I–16. [Epub ahead of print 10 March 2020]. doi: https://doi.org/10.7326/P20-0003
Download citation file:
Published: Ann Intern Med. 2020;172(7):I-16.
Published at www.annals.org on 10 March 2020
Cardiology, Rhythm Disorders and Devices.
Results provided by:
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use